Balchem Corp (NASDAQ:BCPC)
The Company is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, feed and medical sterilization industries.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
GlobalTraveler
(85.82)
Submitted: 9/6/2011 10:31:51 AM :
Start Price:
$37.97
BCPC Score:
-24.24
It is a pick and shovel supplier to the biotechnology sector.
Recs
louchios
(< 20)
Submitted: 8/22/2011 12:30:16 AM :
Start Price:
$37.50
BCPC Score:
-22.52
past performance
Recs
Cicciano
(< 20)
Submitted: 8/15/2011 12:40:52 PM :
Start Price:
$34.84
BCPC Score:
-22.51
good company riding a good wider trend. Pricy but if it dips to mid-30s a good buy.
Recs
BlackThought
(< 20)
Submitted: 9/17/2010 10:19:27 AM :
Start Price:
$28.08
BCPC Score:
-6.53
overvalued and right at resistance.
Recs
mighelinger
(< 20)
Submitted: 9/16/2010 11:32:17 AM :
Start Price:
$27.55
BCPC Score:
+8.76
It's chart has outperformed for several months continuously
Recs
alfred13
(90.50)
Submitted: 2/2/2010 9:40:41 AM :
Start Price:
$19.31
BCPC Score:
+59.80
Good steady performer, with dividends and growth that will outperform s&p
Recs
BuffetsMentor
(23.54)
Submitted: 12/27/2009 9:33:24 PM :
Start Price:
$22.71
BCPC Score:
+36.42
splitting
Recs
crashpik
(< 20)
Submitted: 12/22/2009 2:35:35 PM :
Start Price:
$22.54
BCPC Score:
+36.42
This company keeps beating earnings estimates and keeps setting new 52-wk highs as well. Excellent growth and outrunning S&P by a long shot.
Recs
homdet
(< 20)
Submitted: 11/14/2008 7:24:28 PM :
Start Price:
$14.87
BCPC Score:
+77.84
The convergence of positive investment measures, which should help this stock outperform the majority of stocks. The company's strengths can be seen in multiple areas, such as its robust revenue growth, growth in earnings per share, solid stock price performance and increase in net income. The strengths outweigh the fact that the company shows low profit margins.
Recs
rwhite3651
(61.15)
Submitted: 11/3/2008 12:30:02 PM :
Start Price:
$16.82
BCPC Score:
+68.19
Solid company
Recs
foolmenottwice
(51.72)
Submitted: 10/30/2008 5:42:05 AM :
Start Price:
$15.29
BCPC Score:
+87.31
a real bargin at the price today 10/29/08
Recs
brolandz
(< 20)
Submitted: 7/1/2008 4:24:49 PM :
Start Price:
$16.27
BCPC Score:
+108.11
Guessing again!
Recs
TMFStockpick08
(76.71)
Submitted: 5/27/2008 10:32:16 AM :
Start Price:
$14.99
BCPC Score:
+134.31
This stock was picked by TMFBreakerDave in the 2008 TMF Stockpicking Contest.
Recs
bbubbba
(< 20)
Submitted: 5/9/2008 10:43:17 PM :
Start Price:
$15.24
BCPC Score:
+131.63
Solid growth!
Recs
BigDogBlog
(68.57)
Submitted: 4/12/2008 11:36:25 AM :
Start Price:
$15.02
BCPC Score:
+129.94
Maltbie's Mix
Long On BCPC, Short On INTU
Robert Maltbie 03.24.08, 4:15 PM ET
*****************************************************************
Balchem is a manufacturer of specialty performance ingredients for the food, animal feed, pharmaceutical and medical sterilization industries. The company's products provide essential nutrients for animal health and enhance therapeutic performance, taste, packaging and shelf life for human food and pharmaceutical markets.
We see 20% to 25% top line and bottom line growth, with 2008 earnings per share (EPS) reaching $1.10, driven by the following factors:
1. Strong demand for poultry in emerging economies is driving demand for choline, an essential poultry nutrient. Acquisitions have quadrupled Balchem's choline business.
2. Encapsulated products in the dairy market deliver nutrients in the harsh environment of the bovine gastrointestinal tract. The company's proprietary products have minimal competition and only a 10% domestic market penetration.
3. Encapsulated products in human nutrition deliver essential nutrients in frozen and packaged foods, including health bars and drinks. The company's encapsulation technology and domestic demand for packaged foods and nutritious snacks are driving growth.
4. Pharmaceutical applications for Balchem's encapsulation technology include calcium products for osteoporosis. Several research and development projects are in place to investigate the use of Balchem's technology with existing ethical and generic drugs.
There are two risks for this purchase. First, increases in raw material prices for choline production have pressured gross margins in 2007. Second, demand growth for poultry products in emerging economies may soften with weaker growth brought on by U.S. economic vulnerability
Recs
bobbob12345
(< 20)
Submitted: 2/13/2008 4:01:02 PM :
Start Price:
$14.76
BCPC Score:
+136.96
its good today it might last a little longer
Recs
sgtterry
(90.73)
Submitted: 9/16/2007 10:00:23 PM :
Start Price:
$11.96
BCPC Score:
+199.81
Better Investing Aug 2007
Recs
doggetla
(70.56)
Submitted: 5/20/2007 7:45:36 PM :
Start Price:
$11.29
BCPC Score:
+219.66
undervalued specialty chem manufactor - rated top small-cap by The Street - i still like Catherine Zeta Jones much, much better
Recs
BcpMiddWbsn
(< 20)
Submitted: 12/18/2006 6:39:30 PM :
Start Price:
$10.79
BCPC Score:
+226.42
BalChem rules.
Consistent management; Great acquisition integration; nothing stopping them from continuing their growth; beautifully cautious and successful expansion of their product lines.
Solid sales growth. (Net) debt-free.
Excellent bottom line growth- 475% over last 9 years...21.5%/year.
I like this stock as much as I like Catherine Zeta Jones, and BalChem's got sexier figures. Listing on the Nasdaq should give it more exposure.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 19 of 19